BlackRock’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,237,157
| Closed | -$578M | – | 5256 |
|
|
2020
Q3 | $578M | Sell |
4,237,157
-242,628
| -5% | -$25.8M | 0.02% | 673 |
|
|
2020
Q2 | $433M | Buy |
4,479,785
+350,107
| +8% | +$29.2M | 0.02% | 809 |
|
|
2020
Q1 | $194M | Sell |
4,129,678
-13,132
| -0.3% | -$842K | 0.01% | 1197 |
|
|
2019
Q4 | $302M | Buy |
4,142,810
+259,774
| +7% | +$15.8M | 0.01% | 1176 |
|
|
2019
Q3 | $203M | Buy |
3,883,036
+275,308
| +8% | +$14.6M | 0.01% | 1394 |
|
|
2019
Q2 | $181M | Buy |
3,607,728
+577,590
| +19% | +$28.1M | 0.01% | 1509 |
|
|
2019
Q1 | $158M | Buy |
3,030,138
+168,550
| +6% | +$7.76M | 0.01% | 1581 |
|
|
2018
Q4 | $140M | Buy |
2,861,588
+9,099
| +0.3% | +$501K | 0.01% | 1579 |
|
|
2018
Q3 | $186M | Buy |
2,852,489
+225,030
| +9% | +$13.2M | 0.01% | 1539 |
|
|
2018
Q2 | $130M | Buy |
2,627,459
+822,404
| +46% | +$39.8M | 0.01% | 1765 |
|
|
2018
Q1 | $88.1M | Sell |
1,805,055
-115,596
| -6% | -$6.01M | ﹤0.01% | 1933 |
|
|
2017
Q4 | $80.9M | Buy |
1,920,651
+521,031
| +37% | +$20.1M | ﹤0.01% | 1996 |
|
|
2017
Q3 | $60M | Buy |
1,399,620
+545,911
| +64% | +$17.4M | ﹤0.01% | 2173 |
|
|
2017
Q2 | $11.2M | Buy |
853,709
+205,611
| +32% | +$2.71M | ﹤0.01% | 3107 |
|
|
2017
Q1 | $8.52M | Buy |
648,098
+647,427
| +96,487% | +$8.29M | ﹤0.01% | 3184 |
|
|
2016
Q4 | $9K | Buy |
671
+100
| +18% | +$1.54K | ﹤0.01% | 3425 |
|
|
2016
Q3 | $9K | Buy |
571
+154
| +37% | +$2.78K | ﹤0.01% | 3422 |
|
|
2016
Q2 | $5K | Buy |
417
+301
| +259% | +$3.76K | ﹤0.01% | 3526 |
|
|
2016
Q1 | $1K | Buy |
+116
| New | +$1.05K | ﹤0.01% | 3595 |
|
BlackRock's MYOK Position: Q4 2020 in Review
BlackRock sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,237,157 shares — an estimated $578M sold.
BlackRock first reported a position in MYOK in Q1 2016 and held it in 19 quarters. The position peaked at $578M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- BlackRock reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- BlackRock sold 4,237,157 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $578M.
- BlackRock first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 19 quarters.
- BlackRock's MyoKardia, Inc. Common Stock position peaked at $578M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.